This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2 July - 8 July 2017 and includes updates on measles, Ebola virus disease, influenza A(H7N9), Legionnaires' disease, poliomyelitis and West Nile fever.
This report explores how methods of evidence-based medicine (EBM) can be applied in public health in the field of infectious diseases. It addresses questions related to giving evidence-based advice in situations where there is little evidence and shortness of time. Moreover, the need for adaptation of EBM tools for a public health setting, the usefulness of existing guideline development tools and the use of consensus methods in a setting of evidence-based public health are also examined in the report, as well as future challenges and research needs.
This is an external quality assessment (EQA) scheme for Neisseria gonorrhoeae antimicrobial susceptibility established in 2007 as part of the European Surveillance to STIs programme.
Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
The purpose of this document is to describe the data transport format and the procedure for reporting infectious disease surveillance data to ECDC using TESSy.
This publication presents the core European protocol for a series of proposed influenza vaccine effectiveness studies. The protocol includes a proposed plan for pooled analysis and has recently been adapted to measure vaccine effectiveness for the pandemic vaccine in 2009-10. Together with its twin publication ‘Protocols for cohort database studies to measure influenza vaccine effectiveness in the EU and EEA Member States’, this publication covers all methodological issues in the design and implementation of vaccine effectiveness studies, both for seasonal and the new A(H1N1)v influenza.